GPCR Therapeutics Expands Scientific Advisory Board
May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage international biopharmaceutical...
top of page
Ecosystem
Beta Site
Blog: Blog2
GPCR News
Search
GPCR News
Apr 30, 20221 min read
Domain Therapeutics Raises $42m Series A Financing
May 2022 "Published: May 10, 2022 To accelerate clinical development of its best-in-class and first-in-class immuno-oncology programs...
00
GPCR News
Mar 31, 20221 min read
John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to ...
April 2022 John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to treat pain without the...
10
GPCR News
Mar 31, 20221 min read
Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery...
70
GPCR News
Mar 31, 20221 min read
Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist
April 2022 "By Cliona MacSweeney | Apr 20, 2022 Cliona MacSweeney, a project director in our Translational Medicine department, recently...
20
GPCR News
Mar 31, 20221 min read
Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of ...
April 2022 Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of Ultrahigh Throughput Drug...
20
GPCR News
Mar 31, 20221 min read
Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
April 2022 "SAN DIEGO, April 12, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused...
00
GPCR News
Mar 31, 20221 min read
Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
April 2022 Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group...
20
GPCR News
Mar 31, 20221 min read
Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
April 2022 Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with...
10
GPCR News
Mar 31, 20221 min read
Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
April 2022 Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage of its Evolution "New team...
20
GPCR News
Mar 31, 20221 min read
Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...
April 2022 Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with Tim Dyer Addex Therapeutics...
00
GPCR News
Mar 31, 20221 min read
ShouTi Pharma CEO Dr. Raymond Stevens was interviewed by Moira Gunn of the NPR TechNation podcast
April 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
120
GPCR News
Mar 31, 20221 min read
Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
April 2022 Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment Of Schizophrenia & Other...
00
GPCR News
Mar 31, 20221 min read
Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
April 2022 Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical Study "Geneva, Switzerland,...
10
GPCR News
Feb 28, 20221 min read
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
March 2022 "February 17, 2022 08:00 AM Eastern Standard Time SAN FRANCISCO & SHANGHAI- ShouTi Inc., a clinical-stage global...
120
GPCR News
Feb 28, 20221 min read
Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
March 2022 Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment Of Neuropathic Pain "—...
10
GPCR News
Feb 28, 20221 min read
Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
March 2022 "Geneva, Switzerland, March 7, 2022 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company...
30
GPCR News
Feb 28, 20221 min read
Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial "MONTREAL (CANADA) –...
20
GPCR News
Feb 28, 20221 min read
Exscientia welcomes Richard J. Law, as their new Chief Business Officer
March 2022 "Congratulations to Richard J. Law, our newly named Chief Business Officer. Richard is the architect behind nearly all of...
10
GPCR News
Feb 28, 20221 min read
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance, to develop first-in...
20
bottom of page